Background/Aims: Cocaine- and amphetamine-regulated transcript (CART) is an anorexigenic regulatory peptide highly expressed in the brain’s appetite control centers, but also in peripheral neurons and in endocrine cells in the adrenal medulla, thyroid, pancreatic islets, and in the gastrointestinal tract. Plasma levels of CART were recently shown to be elevated in patients with neuroendocrine tumors (NETs), but the cellular sources of CART in NETs have remained unknown. The aim of the study was to establish whether CART is expressed in various types of NETs and, if so, to examine the frequency, distribution and phenotype of CART-expressing cells. Methods: Tumor specimens from 133 NETs originating in the stomach, ileum, rectum, pancreas and thyroid were examined with immunohistochemistry and in situ hybridization. The expression of CART was quantified and the CART-expressing cells were phenotyped by double staining for established markers and hormones. Results: CART-expressing tumor cells were found in the majority of the examined NETs. The expression pattern of CART was highly heterogeneous not only between tumors, but also within individual tumors. In 14% of the NETs, CART was found in a major population of the tumor cells. Conclusion: CART is produced in the majority of NETs, regardless of tumor origin. This likely explains the elevated levels of circulating CART in certain NETs patients, as recently described. CART could therefore prove to be a useful tool in the diagnostics of NETs not only in blood samples, but also in histopathological specimens.

Keywords:
Neuroendocrine tumors, Endocrine pancreatic tumors, Gastrointestinal tract, Medullary thyroid carcinomas, Regulatory peptides, Cocaine- and amphetamine-regulated transcript
1.
Douglass J, McKinzie AA, Couceyro P: PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 1995;5:2471–2481.
2.
Rogge G, Jones D, Hubert GW, Lin Y, Kuhar MJ: CART peptides: regulators of body weight, reward and other functions. Nat Rev Neurosci 2008;9:747–758.
3.
Jensen PB, Kristensen P, Clausen JT, Judge ME, Hastrup S, Thim L, Wulff BS, Foged C, Jensen J, Holst JJ, Madsen OD: The hypothalamic satiety peptide CART is expressed in anorectic and non-anorectic pancreatic islet tumors and in the normal islet of Langerhans. FEBS Lett 1999;447:139–143.
4.
Wierup N, Kuhar MJ, Nilsson BO, Mulder H, Ekblad E, Sundler F: Cocaine- and amphetamine- regulated transcript (CART) is expressed in several islet cell types during rat development. J Histochem Cytochem 2004;52:169–177.
5.
Wierup N, Sundler F: CART is a novel islet regulatory peptide. Peptides 2006;27:2031–2036.
6.
Ekblad E, Kuhar M, Wierup N, Sundler F: Cocaine- and amphetamine-regulated transcript (CART): distribution and function in rat gastro-intestinal tract. Neurogastroenterol Motil 2003;15:1–13.
7.
Ekblad E: CART in the enteric nervous system. Peptides 2006;27:2024–2030.
8.
Wierup N, Gunnarsdóttir A, Ekblad E, Sundler F: Characterisation of CART-containing neurons and cells in the porcine pancreas, gastro-intestinal tract, adrenal and thyroid glands. BMC Neurosci 2007;8:51.
9.
Dun SL, Brailoiu GC, Yang J, Chang JK, Dun NJ: Cocaine- and amphetamine-regulated transcript peptide and sympatho-adrenal axis. Peptides 2006;27:1949–1955.
10.
Wierup N, Kask L, Sörhede-Winzell M, Kuhar M, Ahrén B, Sundler F: CART is a regulator of islet function and a possible incretin hormone (abstract). Islet and Beta Cell Biology Meeting, Snowbird, 2008.
11.
Larsson LI, Grimelius L, Håkanson R, Rehfeld JF, Stadil F, Holst J, Angervall L, Sundler F: Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol 1975;79:271–284.
12.
Alumets J, Alm P, Falkmer S, Håkanson R, Ljungberg O, Mårtensson H, Sundler F, Tibblin S: Immunohistochemical evidence of peptide hormones in endocrine tumors of the rectum. Cancer 1981;48:2409–2415.
13.
Wilander E, El-Salhy M, Lundqvist M, Grimelius L, Terenius L, Lundberg JM, Tatemoto K, Schwartz TW: Polypeptide YY (PYY) and pancreatic polypeptide (PP) in rectal carcinoids: an immunocytochemical study. Virchows Arch A Pathol Anat Histopathol 1983;401:67–72.
14.
Mårtensson H, Nobin A, Sundler F, Falkmer S: Endocrine tumors of the ileum. Cytochemical and clinical aspects. Pathol Res Pract 1985;180:356–363.
15.
Cunningham JL, Janson ET, Agarwal S, Grimelius L, Stridsberg M: Tachykinins in endocrine tumors and the carcinoid syndrome. Eur J Endocrinol 2008;159:275–282.
16.
Wierup N, Björkqvist M, Kuhar MJ, Mulder H, Sundler F: CART regulates islet hormone secretion and is expressed in the β-cells of type 2 diabetic rats. Diabetes 2006;55:305–311.
17.
Wierup N, Richards WG, Bannon AW, Kuhar MJ, Ahrén B, Sundler F: CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight. Regul Pept 2005;129:203–211.
18.
Asnicar MA, Smith DP, Yang DD, Heiman ML, Fox N, Chen YF, Hsiung HM, Köster A: Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinology 2001;142:4394–4400.
19.
del Giudice EM, Santoro N, Cirillo G, D’Urso L, Di Toro R, Perrone L: Mutational screening of the CART gene in obese children: identifying a mutation (Leu34Phe) associated with reduced resting energy expenditure and cosegregating with obesity phenotype in a large family. Diabetes 2001;50:2157–2160.
20.
Järhult J, Landerholm K, Falkmer S, Nordenskjöld M, Sundler F, Wierup N: First report on metastasizing small bowel carcinoids in first-degree relatives in three generations. Neuroendocrinology 2010;91:318–323.
21.
Friis-Hansen L, Wierup N, Rehfeld JF, Sundler F: Reduced ghrelin, islet amyloid polypeptide, and peptide YY expression in the stomach of gastrin-cholecystokinin knockout mice. Endocrinology 2005;146:4464–4471.
22.
Wierup N, Björkqvist M, Weström B, Pierzynowski S, Sundler F, Sjölund K: Ghrelin and motilin are cosecreted from a prominent endocrine cell population in the small intestine. J Clin Endocrinol Metab 2007;92:3573–3581.
23.
Mulder H, Lindh AC, Sundler F: Islet amyloid polypeptide gene expression in the endocrine pancreas of the rat: a combined in situ hybridization and immunocytochemical study. Cell Tissue Res 1993;274:467–474.
24.
Rindi G, Arnold R, Bosman FT, Capella C, Klimstra DS, Klöppel G, Komminoth P, Solcia E: Nomenclature and classification of neuroendocrine neoplasms of the digestive system; in Bosman FT, Carneiro F, Hruban RH, Theise ND (eds): WHO Classification of Tumours of the Digestive System. Lyon, IARC, 2010.
25.
Öberg K, Astrup L, Eriksson B, Falkmer SE, Falkmer UG, Gustafsen J, Haglund C, Knigge U, Vatn MH, Valimaki M: Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). II. Specific NE tumour types. Acta Oncol 2004;43:626–636.
26.
Bech P, Winstanley V, Murphy KG, Sam AH, Meeran K, Ghatei MA, Bloom SR: Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancy. J Clin Endocrinol Metab 2008;93:1246–1253.
27.
Stein J, Steiner DF, Dey A: Processing of cocaine- and amphetamine-regulated transcript (CART) precursor proteins by prohormone convertases (PCs) and its implications. Peptides 2006;27:1919–1925.
28.
Creutzfeldt W: Pancreatic endocrine tumors – the riddle or their origin and hormone secretion. Isr J Med Sci 1975;11:762–776.
29.
Månsson B, Ahrén B, Nobin A, Böttcher G, Sundler F: Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma. Surgery 1990;107:182–186.
30.
Mårtensson H, Böttcher G, Sundler F, Nobin A: Localization and peptide content of endocrine pancreatic tumors. Ann Surg 1990;212:607–614.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.